# Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma

> **NCT05236439** · NA · COMPLETED · sponsor: **Ciliatech** · enrollment: 57 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Glaucoma, Narrow Angle

## Interventions

- **DEVICE:** Interposition supraciliary implant

## Key facts

- **NCT ID:** NCT05236439
- **Lead sponsor:** Ciliatech
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-23
- **Primary completion:** 2025-02-19
- **Final completion:** 2025-11-03
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236439, "Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT05236439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*